Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gluma Desensitizer for Post-Operative Sensitivity in Composite Restorations
NCT07188142Phase 3Not yet recruiting
- Start
- Dec 2025
- Primary completion
- May 2026
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Gluma Desensitizer in dentin hypersensitivity (DH). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Gluma Desensitizer
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT07188142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07188142.